DOCS
Doximity, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth -4.8% ·
share flow -0.5% ·
net new positions -10.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | -9 | 99.96M | $2.07B | +7 | −17 |
| Q1 2026 | 124 | -12 | 93.12M | $2.18B | +2 | −15 |
| Q4 2025 | 137 | +3 | 98.50M | $4.36B | +5 | −1 |
| Q3 2025 | 20 | -1 | 62.52M | $4.57B | — | −2 |
| Q2 2025 | 19 | 0 | 60.43M | $3.71B | +1 | −1 |
| Q1 2025 | 16 | -1 | 22.41M | $1.30B | +1 | −2 |
| Q4 2024 | 17 | +2 | 19.67M | $1.05B | +2 | — |
| Q3 2024 | 14 | +1 | 14.27M | $621.81M | +2 | −1 |
| Q2 2024 | 13 | — | 13.99M | $391.40M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 14.72M | -1.4% | $1.08B | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 2 | The Vanguard Group ✦ (passive) | 12.77M | +0.1% | $933.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 8.78M | -20.9% | $642.08M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 4 | Capital World Investors ✦ | 5.38M | +25.8% | $393.65M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 4.03M | 0.0% | $294.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 3.85M | -2.1% | $281.61M | 0.2% | ▼ Trim | 6 | SEC ↗ ×4 |
| 7 | Geode Capital Management ✦ (passive) | 3.83M | +5.3% | $281.26M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Renaissance Technologies ✦ | 2.18M | -1.6% | $159.48M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 1.32M | — | $96.58M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 10 | Arrowstreet Capital ✦ | 1.17M | -5.1% | $85.85M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.13M | +837.6% | $82.53M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 905.21K | — | $66.22M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 13 | Millennium Management ✦ | 660.62K | +30.4% | $48.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 618.07K | +471.0% | $45.21M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 435.54K | +3.4% | $31.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 16 | Gotham Asset Management ✦ | 320.58K | +217.3% | $23.45M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Goldman Sachs Group ✦ | 298.52K | — | $21.84M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 18 | D. E. Shaw & Co. ✦ | 74.31K | -91.1% | $5.44M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Citadel Advisors ✦ | 31.72K | -43.6% | $2.32M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 20 | Wellington Management ✦ | 16.75K | -31.2% | $1.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Norges Bank | $6.20M | was 0.0% |
| Two Sigma Investments | $2.95M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 418 holders, 119.59M shares, $2.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 2.00K sh · $57,820
Director · 1.29K sh · $34,456
Officer · 2.08K sh · $54,044
Director · 2.00K sh · $52,660
Director · 2.00K sh · $49,900
Officer · 1.77K sh · $44,144
Director · 7.50K sh · $293,325
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology